acetonitrile has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaiswal, DP; Kumbhar, BV; Palakhe, SS; Patil, AF; Patil, SP; Patil, VS | 1 |
| Gurupadayya, BM; Nataraj, V; Nishanth G, VV; Spandana, T; Sri, CD; Vikram, PRH | 1 |
2 other study(ies) available for acetonitrile and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Investigating the novel acetonitrile derivatives as potential SARS-CoV-2 main protease inhibitor using molecular modeling approach.
Topics: Acetonitriles; Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; RNA, Viral; SARS-CoV-2 | 2023 |
Multivariate Optimization for Determination of Favipiravir, a SARS-CoV-2 Molecule, by the Reverse-Phase Liquid Chromatographic Method Using a QbD Approach.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; COVID-19; Humans; SARS-CoV-2 | 2023 |